Pressure BioSciences, Inc.

PBIO · OTC
Analyze with AI
6/30/2024
3/31/2024
12/31/2023
9/30/2023
Assets
Cash & Equivalents$14$3$81$5
Short-Term Investments$0$0$0$0
Receivables$184$145$151$329
Inventory$542$597$305$467
Other Curr. Assets$134$213$223$219
Total Curr. Assets$874$957$760$1,021
Property Plant & Equip (Net)$654$644$228$251
Goodwill$4,774$4,728$0$0
Intangibles$513$596$0$252
Long-Term Investments$64$66$62$78
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$0
Total NC Assets$6,006$6,034$290$581
Other Assets$0$0$0$0
Total Assets$6,879$6,992$1,050$1,602
Liabilities
Payables$2,494$2,439$1,320$1,063
Short-Term Debt$28,674$26,557$22,663$20,967
Tax Payable$0$0$0$0
Deferred Revenue$230$233$234$253
Other Curr. Liab.$12,177$15,340$9,358$7,676
Total Curr. Liab.$43,575$44,569$33,576$29,958
LT Debt$519$541$223$234
Deferred Rev, NC$13$8$5$11
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$532$549$227$244
Other Liabilities$0$0$0$0
Cap. Leases$566$585$128$138
Total Liabilities$44,107$45,118$33,804$30,203
Equity
Pref Stock$0$0$0$0
Common Stock$540$471$354$234
Retained Earnings-$186,193-$177,735-$169,029-$158,493
AOCI$35,894$35,684$35,684$35,684
Other Equity$112,531$103,453$100,237$93,974
Total Equity-$37,228-$38,127-$32,754-$28,601
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$6,879$6,992$1,050$1,602
Net Debt$29,179$27,095$22,805$21,195